Multimorbidity and atopic dermatitis in a population-based cohort: severity-dependent association with distinct nonatopic multimorbidity patterns
Participants with AD, especially moderate-to-severe disease, are more likely to experience (nonatopic) multimorbidity and showed unique patterns of nonatopic multimorbidity with regard to orofacial and cardiometabolic diseases. Our findings highlight the importance of promoting awareness for interdisciplinary approaches to managing patients with AD. An author video to accompany this article is available online.
Authors
- Laura Loman (ORCID: https://orcid.org/0000-0003-2731-9284)
- Josué Almansa Ortíz
- A. B. Sprikkelman (ORCID: https://orcid.org/0000-0002-2617-3538)
- Junfen Zhang (ORCID: https://orcid.org/0000-0001-7816-0328)
- Marie L. A. Schuttelaar (ORCID: https://orcid.org/0000-0002-0766-4382)
- Leon A Miltner (ORCID: https://orcid.org/0009-0003-8184-6584)
Institutions
- University Medical Center Groningen (NL)
- Southern Medical University (CN)
Publication Details
- Journal
- British Journal of Dermatology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1093/bjd/ljaf475
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Eli Lilly and Company
- Pfizer
- Sanofi
- Regeneron Pharmaceuticals
- Aimmune Therapeutics
- Ministerie van Volksgezondheid, Welzijn en Sport
- Universitair Medisch Centrum Groningen
- Galderma
- LEO Pharma
- Sanofi Genzyme